ArticleEuropean urology oncology2024

Enzalutamide Monotherapy in the EMBARK Trial Should Be Practice-changing and Existing Data Suggest How to Mitigate Toxicity.

Lisa M Cordes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.